Published in Biochemistry on January 26, 2010
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. J Biol Chem (2012) 1.48
Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1. Proc Natl Acad Sci U S A (2011) 1.11
Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1). J Biol Chem (2013) 1.11
Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells. Endocrinology (2011) 0.96
Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR. PLoS One (2012) 0.91
The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. PLoS One (2011) 0.85
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments. Sci Rep (2015) 0.80
Helix 8 plays a crucial role in bradykinin B(2) receptor trafficking and signaling. J Biol Chem (2011) 0.80
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Br J Pharmacol (2012) 0.80
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail. J Neurochem (2011) 0.79
A membrane-proximal, C-terminal α-helix is required for plasma membrane localization and function of the G Protein-coupled receptor (GPCR) TGR5. J Biol Chem (2013) 0.79
The Viral G Protein-Coupled Receptor ORF74 Hijacks β-Arrestins for Endocytic Trafficking in Response to Human Chemokines. PLoS One (2015) 0.77
Frizzled-4 C-terminus Distal to KTXXXW Motif is Essential for Normal Dishevelled Recruitment and Norrin-stimulated Activation of Lef/Tcf-dependent Transcriptional Activation. J Mol Signal (2016) 0.75
High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61
Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science (2007) 20.32
A guided tour into subcellular colocalization analysis in light microscopy. J Microsc (2006) 16.73
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature (2007) 14.06
Structure of a beta1-adrenergic G-protein-coupled receptor. Nature (2008) 11.97
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science (2007) 11.74
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science (2008) 11.74
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev (2002) 8.50
Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev (2001) 6.50
Crystal structure of squid rhodopsin. Nature (2008) 4.58
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J Neurosci (1997) 2.25
Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat Cell Biol (2001) 1.99
Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem (1999) 1.82
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci (1999) 1.80
Constitutive endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem (2004) 1.70
The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci (2007) 1.68
A conserved motif for the transport of G protein-coupled receptors from the endoplasmic reticulum to the cell surface. J Biol Chem (2004) 1.66
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins. Proc Natl Acad Sci U S A (2005) 1.62
Cannabinoid transmission and reward-related events. Neurobiol Dis (1998) 1.62
The endocannabinoid nervous system: unique opportunities for therapeutic intervention. Pharmacol Ther (2001) 1.53
The amino terminus of the fourth cytoplasmic loop of rhodopsin modulates rhodopsin-transducin interaction. J Biol Chem (2000) 1.42
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J (2008) 1.40
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol (2008) 1.39
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. FASEB J (2006) 1.37
Retrograde signaling by endocannabinoids. Curr Opin Neurobiol (2002) 1.36
Role of the PAR1 receptor 8th helix in signaling: the 7-8-1 receptor activation mechanism. J Biol Chem (2005) 1.27
Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum. Mol Pharmacol (2008) 1.25
Characterization of the residues in helix 8 of the human beta1-adrenergic receptor that are involved in coupling the receptor to G proteins. J Biol Chem (2006) 1.20
Role of receptor internalization in the agonist-induced desensitization of cannabinoid type 1 receptors. J Neurochem (2007) 1.15
A novel C-terminal motif is necessary for the export of the vasopressin V1b/V3 receptor to the plasma membrane. J Biol Chem (2004) 1.13
Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms. J Biol Chem (2007) 1.13
Regulation of CB1 cannabinoid receptor internalization by a promiscuous phosphorylation-dependent mechanism. J Neurochem (2008) 1.12
Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of Gs. J Neurochem (1999) 1.07
The basic residues in the membrane-proximal C-terminal tail of the rat melanin-concentrating hormone receptor 1 are required for receptor function. Endocrinology (2004) 1.04
CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. Eur J Biochem (2001) 1.03
The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism. Biochim Biophys Acta (2005) 0.97
Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett (1998) 0.95
Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A. Biochem Pharmacol (2003) 0.94
Functional and biophysical analysis of the C-terminus of the CGRP-receptor; a family B GPCR. Biochemistry (2008) 0.93
The hydrophobic amino acid residues in the membrane-proximal C tail of the G protein-coupled vasopressin V2 receptor are necessary for transport-competent receptor folding. FEBS Lett (2005) 0.93
NMR structural comparison of the cytoplasmic juxtamembrane domains of G-protein-coupled CB1 and CB2 receptors in membrane mimetic dodecylphosphocholine micelles. J Biol Chem (2004) 0.92
Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices. Biopolymers (2009) 0.89
Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function. Biochemistry (2004) 0.86
Regulation of Gi by the CB1 cannabinoid receptor C-terminal juxtamembrane region: structural requirements determined by peptide analysis. Biochemistry (1999) 0.86
Unique helical conformation of the fourth cytoplasmic loop of the CB1 cannabinoid receptor in a negatively charged environment. J Struct Biol (2007) 0.86
Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor. Biochim Biophys Acta (2008) 0.83
Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell (2011) 4.78
NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development (2007) 4.21
Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci (2007) 3.39
Age-dependent fate and lineage restriction of single NG2 cells. Development (2011) 2.29
NG2 glial cells provide a favorable substrate for growing axons. J Neurosci (2006) 1.99
Non-stem cell origin for oligodendroglioma. Cancer Cell (2010) 1.95
Dual origin of mesenchymal stem cells contributing to organ growth and repair. Proc Natl Acad Sci U S A (2011) 1.77
Excitability and synaptic communication within the oligodendrocyte lineage. J Neurosci (2010) 1.74
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res (2002) 1.61
Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. Chem Biol (2004) 1.49
NG2 cells: Properties, progeny and origin. Brain Res Rev (2010) 1.49
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. J Biol Chem (2012) 1.48
The fate of synaptic input to NG2 glial cells: neurons specifically downregulate transmitter release onto differentiating oligodendroglial cells. J Neurosci (2010) 1.47
Methionine acts as a "magnet" in photoaffinity crosslinking experiments. FEBS Lett (2006) 1.45
NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord. Neuron Glia Biol (2008) 1.42
Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. J Neurosci (2008) 1.41
Astrocytes in the retrotrapezoid nucleus sense H+ by inhibition of a Kir4.1-Kir5.1-like current and may contribute to chemoreception by a purinergic mechanism. J Neurophysiol (2010) 1.37
Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. Mol Pharmacol (2003) 1.37
NG2 cells are distinct from neurogenic cells in the postnatal mouse subventricular zone. J Comp Neurol (2009) 1.36
An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1. J Biol Chem (2010) 1.32
Optimization of oligodendrocyte progenitor cell culture method for enhanced survival. J Neurosci Methods (2005) 1.24
Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization. Mol Pharmacol (2009) 1.23
Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J Biol Chem (2002) 1.21
Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One (2011) 1.17
The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation. Biochemistry (2006) 1.17
Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. J Biol Chem (2006) 1.15
Mechanisms regulating the expression, self-maintenance, and signaling-function of the bradykinin B2 and B1 receptors. J Cell Physiol (2002) 1.15
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev (2012) 1.15
International practice experiences in pharmacy education. Am J Pharm Educ (2013) 1.14
Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1). J Biol Chem (2013) 1.11
Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci (2011) 1.11
Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization. Biochemistry (2006) 1.09
The PDZ1 domain of SAP90. Characterization of structure and binding. J Biol Chem (2001) 1.09
Architecture of the 99 bp DNA-six-protein regulatory complex of the lambda att site. Mol Cell (2006) 1.09
Interactions that drive Sec-dependent bacterial protein transport. Biochemistry (2007) 1.07
NG2 cells are not a major source of reactive astrocytes after neocortical stab wound injury. Glia (2011) 1.06
A novel function of syndecan-2, suppression of matrix metalloproteinase-2 activation, which causes suppression of metastasis. J Biol Chem (2007) 1.06
Increased NG2(+) glial cell proliferation and oligodendrocyte generation in the hypomyelinating mutant shiverer. Glia (2004) 1.06
Olig2-dependent developmental fate switch of NG2 cells. Development (2012) 1.06
Nucleotide binding induces changes in the oligomeric state and conformation of Sec A in a lipid environment: a small-angle neutron-scattering study. J Mol Biol (2003) 1.05
Oligomeric states of the SecA and SecYEG core components of the bacterial Sec translocon. Biochim Biophys Acta (2006) 1.05
NG2 cells (polydendrocytes): listeners to the neural network with diverse properties. Glia (2014) 1.04
Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J Virol (2007) 1.04
Selective photoaffinity labeling identifies the signal peptide binding domain on SecA. J Mol Biol (2006) 1.04
Mapping peptide hormone-receptor interactions using a disulfide-trapping approach. Biochemistry (2008) 1.03
Modeling a sialic acid binding pocket in the external loops of JC virus VP1. J Biol Chem (2004) 1.03
A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. Proc Natl Acad Sci U S A (2004) 1.03
Signal peptidase I: cleaving the way to mature proteins. Protein Sci (2011) 1.03
Beta1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. Development (2009) 1.02
Mapping ligand-receptor interfaces: approaching the resolution limit of benzophenone-based photoaffinity scanning. Chem Biol Drug Des (2008) 1.01
Demonstration of a specific Escherichia coli SecY-signal peptide interaction. Biochemistry (2004) 0.98
SecA specificity for different signal peptides. Biochemistry (2002) 0.98
Probing the affinity of SecA for signal peptide in different environments. Biochemistry (2005) 0.98
Morphological and physiological interactions of NG2-glia with astrocytes and neurons. J Anat (2007) 0.96
NG2 cells in white matter but not gray matter proliferate in response to PDGF. J Neurosci (2013) 0.95
NMR determination of pKa values in α-synuclein. Protein Sci (2010) 0.94
Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A. Biochem Pharmacol (2003) 0.94
Energetics of SecA dimerization. J Mol Biol (2011) 0.92
The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type. J Am Chem Soc (2006) 0.92
Mapping of the signal peptide-binding domain of Escherichia coli SecA using Förster resonance energy transfer. Biochemistry (2010) 0.92
Association of the cystic fibrosis transmembrane regulator with CAL: structural features and molecular dynamics. Biochemistry (2005) 0.91
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro. Mol Cell Neurosci (2005) 0.91
Cannabinoid receptor-G protein interactions: G(alphai1)-bound structures of IC3 and a mutant with altered G protein specificity. Protein Sci (2002) 0.90
SecB modulates the nucleotide-bound state of SecA and stimulates ATPase activity. Biochemistry (2002) 0.90
Polydendrocytes in development and myelin repair. Neurosci Bull (2013) 0.90
Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices. Biopolymers (2009) 0.89
Structural characterization of the intermolecular interactions of synapse-associated protein-97 with the NR2B subunit of N-methyl-D-aspartate receptors. J Biol Chem (2005) 0.89
Synthesis, chemical reactivity as Michael acceptors, and biological potency of monocyclic cyanoenones, novel and highly potent anti-inflammatory and cytoprotective agents. J Med Chem (2012) 0.89
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations. Protein Sci (2013) 0.88
Defining the retinoid binding site in the rod cyclic nucleotide-gated channel. J Gen Physiol (2005) 0.88
Transient upregulation of Nkx2.2 expression in oligodendrocyte lineage cells during remyelination. Glia (2004) 0.88
Profiling two indole-2-carboxamides for allosteric modulation of the CB1 receptor. J Neurochem (2013) 0.88
NG2 cells are uniformly distributed and NG2 is not required for barrel formation in the somatosensory cortex. Mol Cell Neurosci (2011) 0.87
Structure-activity relationship study of indole-2-carboxamides identifies a potent allosteric modulator for the cannabinoid receptor 1 (CB1). J Med Chem (2013) 0.87
The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. Mol Endocrinol (2005) 0.87
Structure of the third intracellular loop of the human cannabinoid 1 receptor. Biochemistry (2002) 0.87
A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation. Brain Res (2006) 0.86
The role of sialic acid in human polyomavirus infections. Glycoconj J (2006) 0.86
Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1). J Biol Chem (2008) 0.85
Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis. Dis Esophagus (2008) 0.85
Ligand Binding Sensitivity of the Extracellular Loop Two of the Cannabinoid Receptor 1. Drug Dev Res (2010) 0.85
Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gαiβγ: identification of key CB1 contacts with the C-terminal helix α5 of Gαi. J Biol Chem (2013) 0.85
PTH and PTH antagonist induce different conformational changes in the PTHR1 receptor. J Bone Miner Res (2009) 0.84
Optimization of chemical functionalities of indole-2-carboxamides to improve allosteric parameters for the cannabinoid receptor 1 (CB1). J Med Chem (2014) 0.83
Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study. Biochemistry (2002) 0.83
Probing the interaction of SR141716A with the CB1 receptor. J Biol Chem (2012) 0.83
Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides. Chemistry (2008) 0.82
Identification of essential cannabinoid-binding domains: structural insights into early dynamic events in receptor activation. J Biol Chem (2011) 0.82
Defining the Escherichia coli SecA dimer interface residues through in vivo site-specific photo-cross-linking. J Bacteriol (2013) 0.82
Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor. Biochemistry (2002) 0.82
Molecular characterization of a ligand-tethered parathyroid hormone receptor. Biophys Chem (2002) 0.81
Bradykinin B2 receptor signaling: structural and functional characterization of the C-terminus. Biopolymers (2005) 0.80
Conformational changes in the parathyroid hormone receptor associated with activation by agonist. Mol Endocrinol (2008) 0.80
Small-molecule inhibitors of JC polyomavirus infection. J Pept Sci (2014) 0.80